GYRE vs MUFG · rev $53.5M vs P/E 13, $159.03B cap
Gyre Therapeutics Inc. (GYRE) versus Mitsubishi UFJ Financial Group Inc ADR (MUFG) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Mitsubishi UFJ Financial Group Inc ADR (MUFG) is a banks - diversified company listed on US.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
MUFG does not have a complete income-statement cache yet.
GYRE currently screens at market cap $589.9M. MUFG currently screens at market cap $159.03B and trailing P/E 12.6.
Not investment advice. Open the GYRE and MUFG stock pages for the full models.
Not investment advice.